Clinical Trial Update: Low-dose Y90 Treatment Planning for HCC [NA]

View source ↗

Summary

A completed clinical trial investigating low-dose Yttrium-90 treatment planning for hepatocellular carcinoma (HCC) with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of the Liver
• Hepatocellular Carcinoma

Drugs mentioned

• Y-90

Snippet

Sponsor: Emory University | Conditions: HCC, Cancer of Liver | NA | Status: COMPLETED | Results posted: 2022-12-06